Sildenafil and Big Pharma: A Risky Investment ?

The history of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, generating billions in revenue , its patent expiration created a wave of generic competition , significantly eroding its dominance. While some pharmaceutical companies may try to capitalize on related treatments , the pres

read more